Evidence map›Paper›PMID 40382625›Full record

ArticleBMC public health2025

Co-designing interventions with multiple stakeholders to address barriers and promote equitable access to HIV Pre-Exposure Prophylaxis (PrEP) in Black women in England.

Flavien Coukan, Wezi Thamm, Fola Afolabi, Keitumetse-Kabelo Murray, Adam Pattison Rathbone, John Saunders, Christina Atchison, Helen Ward

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Flavien CoukanNational Institute for Health Research Applied Research Collaboration North West London, Chelsea and Westminster Hospital, London, UK. flavien.coukan15@imperial.ac.uk.
Wezi ThammSchool of Pharmacy, Newcastle University, Newcastle Upon Tyne, UK.
Fola AfolabiYouth Involvement and Engagement Lab, London, UK.
Keitumetse-Kabelo MurrayNational Institute for Health Research Applied Research Collaboration North West London, Chelsea and Westminster Hospital, London, UK.
Adam Pattison RathboneSchool of Pharmacy, Newcastle University, Newcastle Upon Tyne, UK.
John SaundersBlood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Division, UK Health Security Agency, London, UK.
Christina AtchisonPatient Experience Research Centre, School of Public Health, Imperial College London, White City Campus, 90 Wood Lane, London, W12 7TA, UK.
Helen WardNational Institute for Health Research Applied Research Collaboration North West London, Chelsea and Westminster Hospital, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlack women are among the populations most underserved by HIV pre-exposure prophylaxis (PrEP) in England, despite higher risk of HIV acquisition. Previous research mostly focused on men who have sex with men (MSM), often neglecting Black women, and overfocused on patient-level barriers while overlooking provider and system-level factors. This study addresses these gaps by investigating barriers and facilitators to PrEP access by involving multiple stakeholders and exploring co-design strategies to tackle these barriers.

methodsThe study used a structured two-phased qualitative approach. In Phase 1, focus groups (FG) were undertaken across three stakeholder streams: Black women, healthcare professionals (HCPs), and a group combining Black women and HCPs. FG allowed for consensus-building exercises on key barriers and facilitators to PrEP access, and their transcripts were analysed via thematic framework analysis using the Capability, Opportunity, Motivation and Behaviour model of behaviour change. In Phase 2, co-design workshops were conducted with the same stakeholder groups to develop interventions targeting the barrier identified as most important using the Behaviour Change Wheel framework. Interventions were evaluated against the APEASE criteria.

resultsPhase 1 identified six key barriers: HIV/PrEP knowledge gaps, restrictive policies, cultural stigma, healthcare system distrust, gendered relationship dynamics, and suboptimal PrEP use. Six facilitators emerged, including improved knowledge, increased accessibility, and addressing discrimination. All stakeholder groups voted for lack of awareness and knowledge as the priority barrier to address. All co-designed interventions consisted of a multimodal PrEP awareness campaign tailored to Black communities, with an emphasis on Black women's involvement to foster trust and engagement. However, the workshops produced different approaches, with Black women focusing on community-led initiatives, and HCPs advocating for government-backed, broader strategies despite known distrust of institutions.

conclusionsThis study highlights the importance of co-designing interventions with Black women to address multi-level barriers to PrEP access. It underscores the need for community education, healthcare system reforms, and the inclusion of Black women in decision-making processes to reduce PrEP equity gaps. The co-designed interventions provided a tailored, context-specific strategy that could improve PrEP uptake among Black women in England.

Indexed as

Black PeopleHealth Services AccessibilityHIV InfectionsPre-Exposure ProphylaxisStakeholder ParticipationAdultEnglandFemaleFocus GroupsHumansMaleMiddle AgedQualitative ResearchCommunity-based participatory researchHealth equityHealth services accessibilityHIV Pre-exposure Prophylaxis (PrEP)Quality improvementSexual healthStakeholder participation

Identifiers

PMID40382625
PMCPMC12085007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.